These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23945807)

  • 1. A proposed ethical framework for prescription drug benefit allocation policy.
    Teagarden JR; Daniels N; Sabin JE
    J Am Pharm Assoc (Wash); 2003 Jan; 43(1):69-74. PubMed ID: 23945807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposed ethical framework for prescription drug benefit allocation policy.
    Teagarden JR; Daniels N; Sabin JE
    J Am Pharm Assoc (Wash); 2003; 43(1):69-74. PubMed ID: 12585754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ethical analysis of the decision-making process in occupational health practice].
    Franco G
    Med Lav; 2005; 96(5):375-82. PubMed ID: 16711638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making "ethical safe space" in the translation of contested knowledge: the role of community debate in defining end-of-life decision ethics.
    Kaufert J; Schwartz K; Wiebe R; Derksen J; Lutfiyya ZM; Richert D
    Palliat Support Care; 2013 Apr; 11(2):123-33. PubMed ID: 23259991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delisting policy reform in South Korea: failed or policy change?
    Lee H; Kim J
    Value Health; 2012 Jan; 15(1):204-12. PubMed ID: 22264990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding legitimacy for the role of budget impact in drug reimbursement decisions.
    Niezen MG; de Bont A; Busschbach JJ; Cohen JP; Stolk EA
    Int J Technol Assess Health Care; 2009 Jan; 25(1):49-55. PubMed ID: 19126251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drugs in Medicare and the ESRD program.
    Powe NR
    Semin Nephrol; 2000 Nov; 20(6):535-42. PubMed ID: 11111855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.
    Franke AG; Northoff R; Hildt E
    Pharmacopsychiatry; 2015 Nov; 48(7):256-64. PubMed ID: 26252723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors.
    Sacchini D; Craxì L; Refolo P; Minacori R; Cicchetti A; Gasbarrini A; Cammà C; Spagnolo AG;
    Dig Liver Dis; 2015 May; 47(5):351-5. PubMed ID: 25534233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On pharmacogenomics in pharmacy benefit management.
    Russell Teagarden J; Stanek EJ
    Pharmacotherapy; 2012 Feb; 32(2):103-11. PubMed ID: 22392418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical models in bioethics: theory and application in organ allocation policies.
    Petrini C
    Minerva Med; 2010 Dec; 101(6):445-56. PubMed ID: 21196904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood Cancer.
    Unguru Y; Fernandez CV; Bernhardt B; Berg S; Pyke-Grimm K; Woodman C; Joffe S
    J Natl Cancer Inst; 2016 Jun; 108(6):djv392. PubMed ID: 26825103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods of providing prescription drug benefits in health plans.
    Curtiss FR
    Am J Hosp Pharm; 1986 Oct; 43(10):2428-35. PubMed ID: 3788994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The study of direct-to-consumer advertising for prescription drugs.
    Schommer JC; Hansen RA
    Res Social Adm Pharm; 2005 Jun; 1(2):348-68. PubMed ID: 17138482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling ethical issues in health technology assessment: a proposed framework.
    Burls A; Caron L; Cleret de Langavant G; Dondorp W; Harstall C; Pathak-Sen E; Hofmann B
    Int J Technol Assess Health Care; 2011 Jul; 27(3):230-7. PubMed ID: 21736860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurse participation in ethical decision making in the clinical setting.
    Dalby J
    AWHONNS Clin Issues Perinat Womens Health Nurs; 1993; 4(4):606-10. PubMed ID: 8220375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ethical assessment framework for addressing global genetic issues in clinical practice.
    Cassells JM; Jenkins J; Lea DH; Calzone K; Johnson E
    Oncol Nurs Forum; 2003; 30(3):383-90. PubMed ID: 12719739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.